Squarepoint’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$196K Buy
+52,879
New +$196K ﹤0.01% 2346
2024
Q4
Sell
-50,320
Closed -$544K 2901
2024
Q3
$544K Sell
50,320
-59,721
-54% -$646K ﹤0.01% 1705
2024
Q2
$2.31M Buy
110,041
+95,422
+653% +$2M ﹤0.01% 1008
2024
Q1
$466K Buy
+14,619
New +$466K ﹤0.01% 1707
2023
Q4
Sell
-47,749
Closed -$608K 2634
2023
Q3
$608K Buy
47,749
+33,056
+225% +$421K ﹤0.01% 1523
2023
Q2
$266K Sell
14,693
-46,665
-76% -$843K ﹤0.01% 1925
2023
Q1
$1.05M Sell
61,358
-768
-1% -$13.2K ﹤0.01% 1136
2022
Q4
$1.38M Buy
+62,126
New +$1.38M 0.01% 946